Form 4: Candel Therapeutics Executive Sells Shares to Cover Tax Obligations

Seshu Tyagarajan, Chief Technology Officer of Candel Therapeutics, sold 13,330 shares of common stock to cover tax withholding obligations related to vesting restricted stock units.

Summary

• On July 11, 2024, Seshu Tyagarajan, the Chief Technology Officer of Candel Therapeutics, Inc. (CADL), sold 13,330 shares of common stock.
• The shares were sold at a price of $5.9734 per share.
• The sale was executed to cover tax withholding obligations associated with the vesting and settlement of restricted stock units, as per the company's mandatory sell-to-cover policy.
• Following the transaction, Tyagarajan directly owns 160,900 shares of Candel Therapeutics.

Sentiment

Score: 6

Explanation: The document describes a routine transaction (sale of shares to cover taxes) by an executive. It's neutral in nature and doesn't suggest any significant positive or negative sentiment regarding the company's prospects.

Industry Context

Sales to cover tax obligations are a common practice among executives receiving equity compensation. This transaction is a routine event and doesn't necessarily indicate a change in the executive's confidence in the company.

Stakeholder Impact

• The sale of shares by an executive could have a minor, temporary impact on the stock price, but is unlikely to have a significant long-term effect on shareholders.
• The transaction does not directly impact employees, customers, suppliers, or creditors.

Key Dates